DDW recently hosted a webinar ‘Discover how iPSC derived cells can be used to support the development of drug and gene therapies’, supported by DefiniGEN. The event outlined how iPSC derived cells can be used to advance the efficiency and efficacy of disease modelling and covered topics including functionality, modelling disease phenotypes, therapeutic modalities and […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!